Search Results - "Schatzberg"
-
1
HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition
Published in Molecular psychiatry (01-04-2017)“…The hypothalamic–pituitary–adrenal (HPA) axis has been implicated in the pathophysiology of a variety of mood and cognitive disorders. Neuroendocrine studies…”
Get full text
Journal Article -
2
Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression
Published in Molecular psychiatry (01-06-2011)“…Several studies have proposed that brain glutamate signaling abnormalities and glial pathology have a role in the etiology of major depressive disorder (MDD)…”
Get full text
Journal Article -
3
Understanding the Efficacy and Mechanism of Action of a Dextromethorphan-Bupropion Combination: Where Does It Fit in the NMDA Versus mu-Opioid Story?
Published in The American journal of psychiatry (01-07-2022)“…Schatzberg discusses the report from Tabuteau et al which indicates that the combination of 90 mg of dextromethorphan and 210 mg of bupropion (AXS-05) is…”
Get full text
Journal Article -
4
Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?
Published in Neuropsychopharmacology (New York, N.Y.) (01-01-2015)“…Large 'real world' studies demonstrating the limited effectiveness and slow onset of clinical response associated with our existing antidepressant medications…”
Get full text
Journal Article -
5
Mechanisms of Action of Ketamine and Esketamine
Published in The American journal of psychiatry (01-12-2021)Get full text
Journal Article -
6
Historiography: Why Should Historians Pay More Attention to Philosophy of Technology?
Published in Technology and culture (01-07-2024)“…The Oxford Handbook of Philosophy of Technology marks the maturity of the philosophy of technology, which has lagged behind the history of technology as a…”
Get more information
Journal Article -
7
Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder
Published in Molecular psychiatry (01-02-2015)“…Conventional antidepressants require 2–8 weeks for a full clinical response. In contrast, two rapidly acting antidepressant interventions, low-dose ketamine…”
Get full text
Journal Article -
8
HPA axis genetic variation, cortisol and psychosis in major depression
Published in Molecular psychiatry (01-02-2014)“…Genetic variation underlying hypothalamic pituitary adrenal (HPA) axis overactivity in healthy controls (HCs) and patients with severe forms of major…”
Get full text
Journal Article -
9
A Word to the Wise About Intranasal Esketamine
Published in The American journal of psychiatry (01-06-2019)“…Schatzberg discusses the study of Popova et al regarding intranasal esketamine, the putatively more effective enantiomer of ketamine. This pivotal phase 3…”
Get full text
Journal Article -
10
HPA axis in psychotic major depression and schizophrenia spectrum disorders: Cortisol, clinical symptomatology, and cognition
Published in Schizophrenia research (01-11-2019)“…The Hypothalamic Pituitary Adrenal (HPA) axis has been implicated in the pathophysiology of a variety of mood and cognitive disorders. Neuroendocrine studies…”
Get full text
Journal Article -
11
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Published in JAMA psychiatry (Chicago, Ill.) (01-04-2017)“…Several studies now provide evidence of ketamine hydrochloride's ability to produce rapid and robust antidepressant effects in patients with mood and anxiety…”
Get more information
Journal Article -
12
An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression
Published in The American journal of psychiatry (01-12-2022)“…Schatzberg discusses the report by Price et al that automated self-associated training (ASAT) was statistically better than sham treatment in maintaining the…”
Get full text
Journal Article -
13
Common Abnormalities and Disorder-Specific Compensation During Implicit Regulation of Emotional Processing in Generalized Anxiety and Major Depressive Disorders
Published in The American journal of psychiatry (01-09-2011)“…Processing deficits were observed in the ventral anterior cingulate and amygdala of patients with major depression and/or generalized anxiety disorder, but…”
Get full text
Journal Article -
14
A Word to the Wise About Ketamine
Published in The American journal of psychiatry (01-03-2014)Get full text
Journal Article -
15
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Published in American Journal of Psychiatry (01-12-2018)“…Objective:In addition to N-methyl-d-aspartate receptor antagonism, ketamine produces opioid system activation. The objective of this study was to determine…”
Get full text
Journal Article -
16
Some Comments on Psychedelic Research
Published in The American journal of psychiatry (01-05-2020)“…Schatzberg reflects on the effort of the American Psychiatric Association's Council of Research to review studies on psychedelics and psychedelic-assisted…”
Get full text
Journal Article -
17
Can Target Engagement Studies Miss Their Targets and Mislead Drug Development?
Published in The American journal of psychiatry (01-05-2021)“…The study by Costi ct aL (1), in this issue of the Journal, reports exciting data that a potassium anion channel modulator, ezogabinc, has a significant effect…”
Get full text
Journal Article -
18
Resting-state connectivity biomarkers define neurophysiological subtypes of depression
Published in Nature medicine (01-01-2017)“…Using functional MRI in a large multisite sample of more that 1,000 patients, four distinct neurophysiological biotypes of depression are defined. These…”
Get full text
Journal Article -
19
Inference of cell type content from human brain transcriptomic datasets illuminates the effects of age, manner of death, dissection, and psychiatric diagnosis
Published in PloS one (17-07-2018)“…Psychiatric illness is unlikely to arise from pathology occurring uniformly across all cell types in affected brain regions. Despite this, transcriptomic…”
Get full text
Journal Article -
20
Neurobiological Signatures of Anxiety and Depression in Resting-State Functional Magnetic Resonance Imaging
Published in Biological psychiatry (1969) (15-02-2015)“…Abstract Background There is increasing interest in using neurobiological measures to inform psychiatric nosology. It is unclear at the present time whether…”
Get full text
Journal Article